Myasthenia Gravis Support Group
Myasthenia gravis (MG) is a neuromuscular disease leading to fluctuating muscle weakness and fatiguability. The hallmark of myasthenia gravis is muscle weakness that increases during periods of activity and improves after periods of rest. Although myasthenia gravis may affect any voluntary muscle, muscles that control eye and eyelid movement, facial expression, and...
https://myastheniagravisnews.com/2018/06/07/myasthenia-gravis-pivotal-phase-3-trial-argenx-efgartigimod-on-track/
It is in trials and I believe is given as an infusion. I am glad that they are also including seronegative MG patients in the trials as there seem to be a lot of us.
If I understand that, it gets rid of our immune system created bad antibodies -- sort of a direct attack on what is our problem.
The phase 2 study results "While safety and tolerability of the treatment were the study’s primary objective, researchers also evaluated ARGX-113’s effectiveness. Using four tools to measure the treatment’s impact on disease severity, it became clear that ARGX-113 improved scores on all four compared to placebo. Specifically, 75% of patients treated with the investigational therapy had clinically and statistically significant improvement through at least six weeks compared to 25% of patients on placebo."
Improvements already were seen after one week of the four weekly infusions. The treatment also lowered the levels of antibodies, a measure that correlated with patients’ disease severity.
An interesting note on the last sentence above -- level of antibodies correlated with patient diseases severity -- that is something that most of the time we hear is not the case.
It also says the drug was given by infusion, but they were also testing a "subcutaneous" version.
Agreed, there follows a snip from a conversation with my Neurologist the other week.
"Anti-acetylcholine receptor antibodies are odd. Some patients have multiple symptoms and only very low levels of antibodies whereas others even with high levels are controlled on pyridostigmine alone".
Makes me wonder what else is in play and perhaps offers an explanation why so many of us have different symptoms and indeed severity. Interesting that they are arguably going for the result rather than the cause albeit I do appreciate that not in all people with MG can it be attributed to the antibodies.
http://www.argenx.com/en-GB/content/contact/41/
At this point, I am unsure what happens in the case where the patient has had their Thymus removed? If they were young at the time they do seem to be cured of MG. For us older ones there's no point in removal, it has done its deed. Not everyone has MG, of course, it's a rare disease. I too wonder where the source of our antibodies rests, crack that and I suspect a cure won't be too far away.
Another question. Any ideas at what point our blood started to carry the antibodies - have they always been there, just biding their time?
Perhaps it is also true that irrespective of the level of those antibodies in our blood our muscle receptors are not a constant - other events impact on them?
It would be useful if there was a direct correlation between the level of antibodies and the severity of our MG as it would provide a measure of the efficacy of the drugs we take and in so doing allow far better control of the disease. Sadly, not the case?
https://www.questdiagnostics.com/testcenter/testguide.action?dc=WP_MyastheniaGravis
My own initial blood test results:
Blood Test Name, Date, My test, Normal value
AChR Binding Ab(S) May 22, 2012 5.80 nmol/L <=0.02
Positive for MG
AChR Modulating Ab (S) May 22, 2012 100 % 0-20%
Positive for MG
This serological profile suggests thymoma.
With positive ACHR tests the following were done too
AChR Ganglionic Neuronal Ab, S May 22, 2012 0.00 nmol/L <=0.02 Negative
to rule out dysautonomia-- is an umbrella term used to describe any malfunction of the autonomic nervous system. -- something other than MG
CRMP-5-IgG Western Blot, S May 22, 2012 Neg. Negative
Not sure but maybe for thymus cancer (or other cancers).
Striated Muscle Ab May 22, 2012 Positive 1:120 <1:60
As a serological aid in the diagnosis of thymoma, especially in patients with onset of myasthenia gravis (MG) younger than 45 years. As a screening test for MG in older patients, especially when tests for muscle acetylcholine receptor (AChR) antibodies are negative
GAD65 Ab Assay, S May 22, 2012 0.07 nmol/L <= 0.02 Positive
Diabetes susceptibility and other autoimmune likely--helps doctor decide if prednisone might push me into type 2 diabetes -- and so my neuro was worried about that. Also suggests predisposition to related autoimmune thyrogastric disorders
.
This serological profile suggests thymoma.
I didn't have thymoma. I do have immune system thryroid problem.
I have not had a retest of my blood since 2012. I am in remission and think it would be interesting to see what the test says now, but my neuro says I would have to pay for it -- so we wait until remission goes away -- maybe never!
Nice, for us, not to have to pay for the blood tests - are they very expensive? I also gather that there is a shortage of IVIg and certainly here in the UK strictly limited in its use compared to a few years ago.